Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
暂无分享,去创建一个
S. Jacobsen | O. Borge | O J Borge | V Ramsfjell | L Cui | S E Jacobsen | V. Ramsfjell | L. Cui | S. E. W. Jacobsen | Li Cui
[1] Z. Darżynkiewicz,et al. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. , 1993, Cancer research.
[2] N. Mahmud,et al. Activity of the ligand for c‐mpl, thrombopoietin, in early haemopoiesis , 1996, British journal of haematology.
[3] W. Alexander,et al. Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity. , 1995, The EMBO journal.
[4] I. Weissman,et al. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Williams,et al. Interleukin-1 alpha enhances the in vitro survival of purified murine granulocyte-macrophage progenitor cells in the absence of colony-stimulating factors. , 1988, Blood.
[6] M. Ogawa,et al. CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. , 1996, Blood.
[7] W S Alexander,et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. , 1996, Blood.
[8] C. Eaves,et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Civin,et al. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.
[10] S. Jacobsen,et al. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. , 1996, Blood.
[11] F. Ruscetti,et al. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. , 1995, Blood.
[12] T. Stokke,et al. Transforming growth factor-beta potently inhibits the viability- promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells , 1995 .
[13] H. Snoeck,et al. Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells , 1994, The Journal of experimental medicine.
[14] J. Lotem,et al. Control of programmed cell death in normal and leukemic cells: new implications for therapy. , 1993, Blood.
[15] J. Lotem,et al. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. , 1992, Blood.
[16] M. Ogawa,et al. Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.
[17] S. Emerson,et al. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. , 1996, Blood.
[18] R. Hoffman,et al. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. , 1991, Blood cells.
[19] G. Crooks,et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. , 1996, Blood.
[20] Lesley J. Murray,et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells. , 1996, Blood.
[21] J. Ihle,et al. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] G. Williams,et al. Apoptosis in the immune system , 1994, The Journal of pathology.
[23] R. Hoffman,et al. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. , 1988, The Journal of clinical investigation.
[24] L. To,et al. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. , 1994, Experimental hematology.
[25] W. Vainchenker,et al. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. , 1993, Blood.
[26] K. Ikebuchi,et al. Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hemopoietic stem cells in vitro. , 1992, International journal of hematology.
[27] K. Kaushansky,et al. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. , 1996, Blood.
[28] G. Johnson,et al. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. , 1994, Blood.
[29] V. Broudy,et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. , 1996, Blood.
[30] L. Kanz,et al. Ex vivo expansion of hematopoietic precursor cells , 1996, Current opinion in hematology.
[31] R. Kastelein,et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. , 1995, Blood.
[32] Y. Hirabayashi,et al. Promotion of survival and proliferation by interleukin 3, fcil‐ligand and erythropoietin on early and late appearing spleen colony forming units in culture , 1993, Stem cells.
[33] T. Dexter,et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.
[34] D. Metcalf. Hematopoietic regulators: redundancy or subtlety? , 1993, Blood.
[35] D. Scadden,et al. Functional isolation and characterization of human hematopoietic stem cells. , 1995, Science.
[36] J M Piret,et al. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin , 1996, The Journal of experimental medicine.
[37] K. Kaushansky. Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.
[38] I. Weissman,et al. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[39] Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. , 1994 .
[40] M. Ogawa,et al. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. , 1993, Blood.
[41] C. Begley,et al. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. , 1995, Leukemia.
[42] D. Lacey,et al. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. , 1995, Blood.
[43] H. Miyazaki,et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. , 1996, Blood.
[44] H. Broxmeyer,et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. , 1996, Blood.
[45] M. Moore. Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. , 1991, Blood.
[46] S. Karlsson. Treatment of genetic defects in hematopoietic cell function by gene transfer. , 1991, Blood.
[47] C. Eaves,et al. Methodology of long-term culture of human hemopoietic cells , 1991 .
[48] H. Nakauchi,et al. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. , 1993, Blood.
[49] E. Smeland,et al. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. , 1994, Blood.
[50] A. Ritchie,et al. Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor‐Dependent Cell Line, M07e , 1996, Stem cells.
[51] G Kvalheim,et al. Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. , 1992, Leukemia.
[52] M. Koury,et al. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.
[53] M. Ogawa,et al. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[54] P. Lansdorp,et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.
[55] A. Gurney,et al. Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.
[56] A. Farese,et al. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. , 1996, The Journal of clinical investigation.
[57] Lyman Sd. Biology of flt3 ligand and receptor. , 1995 .
[58] G. Johnson,et al. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells , 1994 .
[59] D. Bodine,et al. Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. , 1991, Blood.